Anafranil (clomipramine hydrochloride) sustained release tablets 75mg are being discontinued by Novartis. This is due to manufacturing issues. The current stock for the Anafranil 75mg sustained release tablets is expected to last until June 2015. Novartis cannot recommend an alternative for when stock is exhausted.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067873
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com